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Screening for asymptomatic deep vein 
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Purpose: To identify the presence of occult deep vein thrombosis (DVT) in surgical 
intensive care unit (SICU) patients and to avoid unnecessary screening, we reviewed our 
experience with routine duplex screening for DVT in SICU patients. 
Methods: Over a 24-month period, all patients who were admitted to an SICU with an 
anticipated length of stay greater than 36 hours were studied to determine the prevalence 
of risk factors for asymptomatic proximal DVT. Risk factors, demographics, and opera- 
tive data were collected and analyzed with multilinear regression, t tests and X 2 analysis. 
Results: There was a 7.5% prevalence of major DVT in the 294 patients tudied. APACHE 
I I  scores (14.5 + 6.24 vs 10.3 ± 3.15; p < 0.0001) and emergent procedures (45.5% vs 
23.2%; p > 0.0344) were associated with DVT by multifactorial analysis. Age was 
significant by univariate analysis. An algorithm based on the presence of any one of the 
three risk factors identified (APACHE I I  score 12 or more; emergent procedures; or age 
65 or greater) could be used to limit screening by 30% while achieving a95.5% sensitivity 
for identification of proximal DVT. 
Conclusion: Absence of all three risk factors indicates a very low risk for DVT (1.1%). 
Screening of SICU patients is indicated because of a high prevalence of asymptomatic 
disease. Patients who have proximal DVT require active therapy and not prophylaxis. 
Costs and resources may be contained by using the above risk factors as a filter for duplex 
screening. (J Vase Surg 1997;26:764-9.) 
Deep vein thrombosis (DVT) and pulmonary 
emboli (PE) are responsible for between 5% and 10% 
of all deaths in United States hospitals. 1-4 Surgical 
procedures remain one of the major risk factors for 
the development of DVT despite a decrease in i ci- 
dence with appropriate prophylaxis. It has become 
increasingly common to use pneumatic ompression 
devices (PCD) with or without subcutaneous hepa- 
rin as an adjunct in high-risk patients. In our practice, 
the use of  PCDs is a routine part ofperioperative care 
in critically ill surgical patients. Because the clinical 
diagnosis of DVT is so inaccurate, s-s duplex scanning 
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has emerged as the gold standard for DVT detection. 
More than one half of  patients who have "typical" 
symptoms do not have DVT, whereas as many as two 
thirds of all significant DVTs are neither ecognized 
nor treated. The use of DVT screening and prophy- 
laxis techniques is justified by its association with 
reduction in DVT and ply.9,10 Duplex ultrasound is 
used for screening of  patients before placement of 
PCDs to identify significant occult DVT. Although 
we do not screen all patients before routine heparin 
prophylaxis, all patients are screened for the presence 
of lower extremity DVT before graded PCDs are 
placed on the legs because of a concern over emboli- 
zation from DVT over which PCDs have been 
placed. Further identification of patients with DVT 
would require therapy with anticoagulation rather 
than prophylaxis. 
Because routine duplex screening for DVT is 
labor intensive and costly, we reviewed our experi- 
ence with this practice in our surgical intensive care 
unit (SICU) population. Our goals were to establish 
the prevalence of occult DVT on entry to the SICU, 
to identify high-risk groups that ,~ould benefit from 
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screening, and to identify low-risk patients on whom 
PCDs could be placed without screening studies. 
METHODS 
Data were collected in an observational case 
study format. 
Patient population. Over a 24-month period 
all patients admitted to the SICU who had an antic- 
ipated minimum stay of greater than 36 hours were 
studied with duplex ultrasound scanning, and demo- 
graphic data were collected. Patients were excluded if
their anticipated length of stay was less than 36 hours 
or if a duplex scan was unable to be obtained in a 
timely fashion (within 6 hours of admission to the 
SICU). All patients were admitted after the opera- 
tion. 
Clinical variables. Data were gathered from pa- 
tient charts in a prospective fashion and entered into 
a computer database for subsequent analysis. Vari- 
ables included demographics, data relating to the 
operative procedure, comorbidities, and known risk 
factors for DVT. Operative data including location 
and type of surgery, estimated blood loss, volume of 
blood and crystalloid transfused, time of operative 
procedure, type of anesthesia, nature of procedure 
(emergency or elective), total joint repair, and pelvic 
surgery were specifically noted. Comorbidities in- 
cluded sepsis, respiratory disease, renal disease, he- 
patic disease, chronic obstructive pulmonary disease, 
malignancy, pregnancy, estrogen hormonal therapy, 
severe infection, stroke, and cardiac disease. Other 
risk factors for DVT examined included: DVT pro- 
phylaxis before SICU admission, prolonged bed- 
rest (>72 hours), history of DVT/PE or stigmata 
of chronic venous disease, obesity, trauma, and 
pelvic or long bone fracture. In addition, because this 
was a heterogeneous population, we determined 
APACHE II scores as a marker of overall acuity of 
illness. 
Ultrasound examinations. Venous duplex scan- 
ning was performed by an ICAVL-accredited labora- 
tory using an Acuson 128 unit with 5- and 7-MHz 
transducers. Studies included examination of the dis- 
tal external i iac veins, common femoral veins, super- 
ficial femoral veins, popfiteal veins, and tibial veins 
bilaterally. Examinations consisted of imaging and 
velocity measurements of all of the above veins seg- 
ments. Compressibility of the veins was examined in 
increments. Veins were also examined for the pres- 
ence of echogenic thrombus by duplex and color 
flow examination. The presence of abnormal wave- 
forms was evaluated with spontaneous flow, respira- 
tory phasicity, and augmentation with distal com- 
Table I. Proximal extension of DVT 
Site No. (frequency) 
Iliac vein 5 (1.7%) 
Common femoral vein 8 (2.7%) 
Superficial femoral vein 6 (2%) 
Popliteal vein 3 (1%) 
pression or dorsiflexion of toes. The superficial 
system--greater and lesser saphenous veins--were 
also imaged and evaluated. DVT was diagnosed by 
the presence of thrombus in the vein, the lack of 
compressibility, absence of flow, or abnormal f ow. 
Economics. Average charges for DVT, PE, and 
duplex examination were obtained for all patients 
hospitalized with the above diagnoses during the 
time period of the study. DVT charge data included 
medication, laboratory studies, and hospital days. PE 
charges included medication, laboratory studies, di- 
agnostic studies, and hospital days. 
Data acquisition and analysis. Data were en- 
tered into the Versiform computer program and 
were subsequently transferred to Microsoft Excel 
and SPSS for data analysis. Data were analyzed with 
multilinear regression, two-tailed t tests for unequal 
variable distribution, and X 2. Significance was taken if 
the p value was less than 0.05. 
RESULTS 
During the study period 294 patients were ad- 
mitted to the SICU and completed the screening 
evaluation. All 294 patients underwent duplex exam- 
ination before the placement of the PCDs. During 
the same time period, 1884 patients were admitted 
to the SICU for less than 36 hours, and 120 patients 
were admitted to the SICU for more than 36 hours 
but were not studied because of an inability to obtain 
studies in a timely fashion. No patients were ex- 
cluded as a result of technical difficulties. 
Of the 294 patients tudied, 22 patients (7.5%) 
had documented DVT in the lower extremity on 
arrival to the SICU. All of the DVTs involved major 
deep veins. The site of the most proximal extension 
of DVT is listed in Table I. No isolated calf DVTs 
were identified. No patients had obvious DVT by 
clinical examination. Characteristics of the patient 
population studied are listed in Table II. 
By univariate analysis, age was found to be asso- 
ciated with asymptomatic DVT. Patients with DVT 
were slightly older, 70.2 + 12.8 years (range, 40 to 
87 years), than those without DVT (63.1 + 15.7 
years; range, 15 to 94 years; p < 0.05). This associa- 
tion was lost on multivariate analysis. Malignancy 
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Table II. Characteristics ofstudy group 
D VT No D VT 
Total group % # % # p 
Age (yr) 
Gender 
Cardiac disease 
Neurologic Procedure 
(CNS/spine) 
Malignancy 24.8% 
Respiratory disease 13.6% 
Renal disease 12.6% 
Obesity 7.5% 
Prolonged bedrest prior to 5.4% 
admission 
Stroke 5.4% 
Hepatic disease 4.8% 
History of DVT 4.8% 
Sepsis 4.1% 
Trauma 2.4% 
Varicose veins 1.7% 
Minutes in operating room 258 
APACHE II score 10.66 
Emergent procedure 24.8% 
63.7 70.2 + 12.8 63.1 + 15.7 <0.05 
53% female 50% 11 53% 145 NS 
45.9% (135) 54.5% 12 45.2% 123 NS 
25% (17%, 8%) 18.2% 4 25.7% 70 NS 
40.9% 9 23.5% 64 0.07 
13.6% 3 13.6% 37 NS 
13.6% 3 12.5% 34 NS 
0 0 8.1% 22 NS 
9.1% 2 5% 14 NS 
9.1% 2 5% 14 NS 
0 0 5% 14 NS 
13.6% 3 4% 11 NS 
9.1% 2 3.7% 10 NS 
0 0 2.6% 7 NS 
0 0 1.8% 5 NS 
250 + 153.6 258.8 + 141.2 NS 
14.5 + 6.24 10.3 + 3.15 0.0001 
45.5% 10 23.2% 63 0.03 
CNS, Central nervous ystem. 
was also more common, although not statistically 
significant, in patients with DVT (40.9% vs 23.5%; 
p = 0.07). Of all the individual variables, only age 
and emergent procedures could be used to predict 
the presence of DVT. Although single risk factors 
were not predictive, APACHE II, a global assess- 
ment of physiologic derangement, was found to pre- 
dict the presence of DVT. The length of operation 
did not influence the prevalence of DVT, although 
all patients underwent surgical procedures that lasted 
greater than 30 minutes. 
Using multiple linear regression analysis, 
APACHE II scores and emergency procedures were 
significantly associated with asymptomatic DVT. Pa- 
tients who were found to have asymptomatic DVTs 
were generally more ill, as determined by APACHE 
II scores, than patients without DVT, 14.5 ___ 6.24 
(range, 4 to 27) versus 10.3 _ 3.15 (range, 0 to 24; 
p = 0.0001). Patients with DVT more frequently 
underwent emergency surgical procedures (45.5% vs 
23.2%) than patients without DVT (p = 0.0344). 
No other factors were found to be significantly asso- 
ciated with the presence of DVT on SICU admission 
/by multivariate analysis. 
The results of an algorithm for selective patient 
screening on the basis of significant risk factors (1, 
APACHE II score ->12; 2, emergent procedures; 
and 3, age ->65) is depicted in Table III. Using this 
algorithm, 87 of the 294 patients who were studied 
(30.3%) had none of the risk factors that had been 
found to be significant for DVT. Only one of these 
87 patients had a DVT (1.1%). The presence of any 
of the three risk factors was associated with a greater 
than 10% prevalence of DVT on arrival in the SICU. 
The presence of all three of the risk factors in a given 
patient yielded a 23% prevalence of DVT (five of 22). 
Of the three risk factors, age greater than 65 years 
included the greatest number of patients with DVT, 
while requiring that half of the SICU patients un- 
dergo screening. However, by using just age for 
screening, 23% of patients who have DVT would be 
missed. Adding the other two criteria, APACHE 
score ---12 and emergent procedures, increased the 
screening pool by 20%, but increased the sensitivity 
of the screening process to 95.5%. This approach still 
avoided screening in 30% of SICU admissions. 
The total charges for treating patients with DVT 
was $6780. Patients with PE incurred an average 
charge of $10,005. The charges for venous duplex 
scanning were $178. 
DISCUSSION 
It is well accepted that patients who undergo 
major surgical procedures are at increased risk for 
having DVT when compared with the average popu- 
lation. Unfortunately, the clinical identification of 
DVT is poor, and the diagnosis is missed in as many 
as two thirds of patients who have proximal DVT. ~s 
Advances in ultrasound technology have allowed this 
method to essentially replace invasivc studies and 
enable clinicians to accurately identify major venous 
thrombi. It is important o identify what clinical 
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Table III. Algorithm for DVT screening 
Risk factor 1 2 3 1 or2 1 or3 2 or3 1, 2, or3 
No. of patients 100 (34%) 
(% population) 
No. of DVT 13 (13%) 
(% DVT in group 
screened) 
No. of missed DVT 9 (4.6%) 
(% DVT in group 
not screened) 
Sensitivity ofscreen 59% 
(% DVT detected) 
74 (28%) 
10 13.5%) 
12 (5.5%) 
45% 
146(50%) 145(49%) 174 (59%) 187(64%) 207(70%) 
17(11.6%) 17(11.7%) i9(10.9%) 20(10.7%) 21(10.1%) 
5(3.4%) 5(3.4%) 3(2.5%) 2(1.9%) 1(1.1%) 
77% 77% 86% 91% 95.5% 
1, APACHE score -> 12; 2, emergent procedure; 3,age -> 65 years. 
criteria are appropriate o identify asymptomatic pa- 
tients for screening to maximize our ability to iden- 
tify DVT and to conserve resources. Many studies 
have examined risk factors associated with DVT and 
have identified the following factors: major surgery, 
prior DVT, age greater than 40 years, malignancy, 
obesity, multiple trauma, varicose veins, myocardial 
infarction, congestive heart failure, stroke, lower ex- 
tremity fracture, hormone therapy, pregnancy, and 
immobility} ,xl Major surgery is classified as a proce- 
dure that requires greater than 30 minutes of general 
anesthesia. Orthopedic surgery is also associated with 
a particularly high rate of DVT, with more than 90% 
occurring on the operated side. 12 
Once DVT develops in a patient, there is a 10% 
risk of subsequent DVTs developing. For patients 
who have more than one DVT, the risk of recurrence 
increases to 20%, even in face of adequate anticoagu- 
lation} 3Age is related in an exponential fashion to 
the development of DVT; the risk of DVT doubles 
with each decade after 40 years of age. 14 Malignancy 
imposes a twofold to threefold increased risk of 
DVT. Multiple trauma patients experience roughly a 
47% incidence of DVT, is with proximal DVT being 
identified in approximately 12%. 11 SICU patients 
typically have many of the above risk factors, and 
adjunctive prophylaxis and screening may be ex- 
pected to decrease the morbidity and mortality rate 
in these patients. 
Current recommendations regarding prophylaxis 
of patients are based on risk factor analysis. The 
importance of treating proximal DVT to prevent PE 
"has been well documented, t6 The importance of 
prophylaxis in the surgical population to decrease 
the incidence of DVT has also been well document- 
ed. 17 Patients at moderate risk may be treated with 
low-dose heparin, graduated compression stocldngs, 
or intermittent compression devices. Combination 
therapy using heparin, dextran, or warfarin with in- 
termittent compression devices is recommended for 
patients at high risk, those with at least three of the 
classically identified risk factors. Combining low- 
dose heparin with PCDs has recently been shown to 
offer a 62% risk reduction for PE in open heart 
patients over heparin prophylaxis alone. 18 Ramos et 
al.18 studied 2786 patients who underwent open 
heart surgery by screening patients who had unex- 
plained hypotension or dyspnea, and found a 4% 
incidence of PE in patients who underwent prophy- 
laxis with low-dose heparin (of 5.24% screened) ver- 
sus 1.5% (of 5.31% screened) in those who were 
treated with low-dose heparin plus PCDs. Despite 
appropriate prophylaxis with low-dose heparin ther- 
apy, in the general surgical population there is an 8% 
to 10% risk of developing DVT. 19,20 This observation 
suggests that PCDs may be indicated in addition to 
giving pharmacologic therapy to increase the efficacy 
of prophylaxis. Current recommendations by the 
manufacturer for the placement of intermittent com- 
pression devices recommend placement only when 
no DVT is present. No statement is issued as to how 
this determination should be made. 
The group of patients who require prolonged 
SICU treatment are already at moderate to high risk 
for development of DVT, and therefore combination 
therapy is often used for prophylaxis. We routinely 
attempt to screen all SICU patients with an antici- 
pated extended stay before placement of PCDs as a 
matter of theoretical nd medicolegal concerns. Al- 
though there are no data to prove that placement of a 
PCD on a limb with proximal DVT would cause an 
increased incidence of PE, screening can obviate this 
problem and in addition would detect occult DVT 
that requires active anticoagulation therapy rather 
than prophylaxis. We have chosen to use the most 
accurate noninvasive method of diagnosis, duplex 
ultrasound, 21 before placing these devices. We there- 
fore performed a retrospective r view to determine 
the prevalence of DVT on admission to the SICU as 
well as the optimal application of a screening strat- 
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egy. We anticipated that screening could be limited 
by identifying a group of patients at high risk and a 
group of patients at low risk for DVT. Previous 
studies have suggested that the risk of DVT is pro- 
portionally related to the number of predisposing 
risk factors. 11 In our study of SICU patients, all of 
the patients underwent major surgical procedures, 
and the majority of patients were greater than 40 
years of age, placing them in the moderate- to high- 
risk group. We have found an APACHE score of 12 
or greater and emergent procedures to be the best 
predictors of a group at particularly high risk for 
DVT in an SICU population. APACHE II scores are 
a severity of disease classification system based on 12 
routine physiologic measurements, age, and previous 
health status. They have been shown to prognosti- 
cally stratify acuity of illness. 28 An increase in 
APACHE scores is associated with an increased risk 
of hospital death. For each 5-point increase in 
APACHE II, there is a significant increase in the 
death rate (APACHE score 5 to 9, ~4%; APACHE 
score 15 to 19, -=-12%). Taken alone, age greater 
than 65 years is a weal;er predictor of DVT. Absence 
of all three risk factors indicates a very low risk for 
DVT. Alternately, the presence of all three risk fac- 
tors should alert the clinician to a very high risk of 
proximal DVT. If used as a filter, screening only 
patients with an APACHE II score of 12 or greater, 
emergent procedures, or age greater than 65 years 
would allow us to eliminate testing in as many as 30% 
of all SICU patients with minimal risk of missing a 
proximal DVT. It is particularly interesting to note 
that all of the asympt0matic DVTs identified were 
proximal, at the level of the popliteal, superficial 
femoral, common femoral, or iliac vein. There may 
have been a number of occult calf vein DVTs, for 
which duplex is less sensitive; however, the clinical 
significance of isolated calf vein DVT is unclear. 
For a screening program to be effective, there 
must be sufficient prevalence of disease in the 
screened population and an effective treatment to 
reduce disease morbidity and mortality rates. Antico- 
agulation therapy is known to reduce mortality and 
morbidity rates from DVT. It has been estimated 
that adequate prophylaxis of surgical patients who 
undergo major procedures may prevent 4000 to 
8000 deaths per year. 22 Prophylaxis of patients 
deemed to be at high risk has been estimated to 
prevent DVT in 1 out of every 10 patients, and to 
save the life of 1 out of every 200 patients. 23 The 
prevalence of DVT in the general surgical population 
may be as high as 25% of patients who undergo major 
general surgical procedures without prophy lax is ,  19,2° 
with proximal DVTs identified in 5% to 7%. Patients 
who undergo pelvic, orthopedic, 12,23 or neurosurgi- 
cal procedures are at higher risk. The overall risk of 
major DVT in the general SICU population was 
7.5%, and the risk was even higher in several sub- 
groups. To put these results into context, compari- 
sons can be made with well-accepted screening pro- 
grams. Fecal occult blood screening isrecommended 
as an important part of routine annual examination i  
individuals greater than 50 years of age. The inci- 
dence of positive results of examinations ranges from 
2% to 6%, depending on whether ehydration is used. 
Of those positive results of examinations, 5% to 10% 
will have cancer and 20% to 40% will have adeno- 
mas.  24 In other words, using the highest estimates, 
0.03% of those screened will have disease. Mammog- 
raptly is also well accepted in the prevention and early 
detection of breast cancer. The incidence of positive 
examinations in mammography is approximately 
6.6%, with a 0.55% incidence of cancer. 2s Screening 
all SICU patients yielded a 7.5% incidence of proxi- 
mal DVT. Based on studies of the natural history of 
proximal DVT,  3,9 40% of asymptomatic DVTs will 
become clinically apparent and 60% will remain un- 
diagnosed. Of the undiagnosed thromboses, 50% 
will develop PE. Thirty percent of patients with PE 
will die, 29% will be diagnosed and treated, and 41% 
will be neither diagnosed nor treated. In comparison 
with fecal occult blood, with a 0.03% incidence of 
disease, and mammography, with a 0.55% incidence 
of disease, screening for DVT has a 7.5% incidence of 
disease, with a potential 2.25% incidence of PE, and a 
0.675% potential mortality rate. We believe that 
these data justify DVT screening in the SICU popu- 
lation. 
The cost-effectiveness of creening asymptomatic 
patients in a moderate- to high-risk population must 
be weighed against the medical and economic risk of 
missing major DVT. We do know that 90% of clini- 
cally important PE originate in proximal ower ex- 
tremity DVTs. 26,27 Furthermore, 25% to 90% of pa- 
tients in whom DVT develops will have postphlebitic 
syndrome. Both of these factors must be taken into 
account when deciding whether it is both economi- 
cally and clinically advisable to limit screening by risk 
factor stratification. Risk-based algorithms will in- 
crease cost-effectiveness. I f  screening is not per- 
formed, the charges for treatment are then based on 
the development of clinically apparent DVT, and PE 
from the asymptomatic DVT. Forty percent will be- 
come clinically apparent and will undergo evaluation 
and treatment, (9 × 178) + (9 x 6780) = $62,622. 
Assuming that of the undiagnosed thromboses, 50% 
will develop PE, 0.65% of patients will be treated for 
PE and 0.675% of patients will die from PE. 3~9 The 
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charges for diagnosis and treatment of the PE will be 
$19,120 (0.65% x 294 x $10,005). Therefore, the 
charges for treating patients without screening for 
DVT would be $62,622 + $i9,120 = $81,742. In 
other words, the average charge per patient would be 
$278.01 ($81742/294) if no screening is used. 
These numbers do not reflect the cost of the deaths 
incurred by foregoing screening or the long-term 
consequences of untreated DVT. The charge of 
treatment per patient with screening is $685.34 
[(294 X $178) + (22 x $6780)]/294. The increase 
in charges incurred by blanket screening of all SICU 
patients averages $407.31 ($685.34 - $278.03) per 
patient. By using the risk-based algorithm to limit 
screening, the charges for treatment per patient would 
be $622.30 [(190 × $178) + (22 X $6780)]/294). 
PCDs have a theoretic risk in patients who have 
established DVT, a group that would more properly 
be treated with full anticoagulation rather than with 
prophylactic measures. These concerns led us to a 
policy of routine screening, which we have retrospec- 
tively examined in this study. On the basis of our 
findings of significant asymptomatic proximal DVT 
in 7.5% of the SICU population on admission, we 
conclude that in the already moderate- to high-risk 
population of patients who require SICU treatment, 
screening before placement of PCDs is indicated. 
Screening and costs may be contained by limiting 
evaluation to those individuals with at least one risk 
factor (APACHE II score of 12 or more, emergent 
procedures, and age 65 years or more) on SICU 
admission. PCDs may be placed without screening in 
those individuals who do not have any of the above 
risk factors with minimal risk of missed proximal 
DVT. 
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